secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2026-08-17T11:05:23+00:00
Accession:  0001493152-26-038624
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD Q2 revenue flat at $1.77M; net loss $14.3M on recall charges
----------------------------------------------------------------------

- Q2 2026 revenue $1.771M, down 0.4% YoY; international up 21% to $2.122M, U.S. negative due to $734K recall credits.
- Net loss $14.324M ($0.17/share) vs $13.151M loss ($0.26/share) in Q2 2025; gross loss $774K incl. $612K inventory impairment.
- Cash and marketable securities $30.4M at June 30, 2026, down from $54.2M at Dec 31, 2025.
- Cost savings actions expected to generate ~$9M annual savings; FDA submissions for CGuard Prime 80 cm and original platform expected later this year.
- CGUARDIANS II 30-day outcomes: 100% device success, no deaths/strokes/MI; CGUARDIANS III enrollment started.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000149315226038624/0001493152-26-038624-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000149315226038624/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-038624

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer